W.K. Evans
Impact in
-
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 10
- Lung Cancer Diagnosis and Treatment 5
- Oncology 12
- Lung Cancer Research Studies 4
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Joseph L. Pater (3 shared papers)Pamela J. Goodwin (1 shared paper)R. Feld (4 shared papers)Ian D. Graham (2 shared papers)George P. Browman (2 shared papers)F. Shepherd (3 shared papers)D. Ian Hodson (1 shared paper)E. Ann Mohide (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)European Journal of Cancer (4 papers)Journal of Thoracic Oncology (3 papers)Lung Cancer (3 papers)CHEST Journal (1 paper)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
W.K. Evans
30 papers receiving 507 citations
Peers
Comparison fields: 5 of 55
- Oncology 198
- Pulmonary and Respiratory Medicine 129
- Economics and Econometrics 118
- Public Health, Environmental and Occupational Health 73
- Cancer Research 34
Countries citing papers authored by W.K. Evans
This map shows the geographic impact of W.K. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.K. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.K. Evans more than expected).
Fields of papers citing papers by W.K. Evans
This network shows the impact of papers produced by W.K. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.K. Evans. The network helps show where W.K. Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside W.K. Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 123 | |
| 2 | 1998 | 106 | |
| 3 | 1988 | 78 | |
| 4 | 1985 | 36 | |
| 5 | 2000 | 35 | |
| 6 | The cost of managing lung cancer in Canada. | 1995 | 30 |
| 7 | Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module. | 1997 | 27 |
| 8 | 2001 | 14 | |
| 9 | 1999 | 12 | |
| 10 | Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer. | 1992 | 11 |
| 11 | 2000 | 8 | |
| 12 | Chemotherapy for relapsed small cell lung cancer: a clinical practice guideline | 2006 | 8 |
| 13 | A model for estimating the costs and burdens of breast cancer diagnosis and treatment in Canada. | 1993 | 8 |
| 14 | Use of vinorelbine in non-small-cell lung cancer. Provincial Lung Disease Site Group. | 1997 | 7 |
| 15 | Use of vinorelbine in non-small-cell lung cancer | 1997 | 7 |
| 16 | 2008 | 6 | |
| 17 | Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a clinical practice guideline | 2006 | 6 |
| 18 | The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a clinical practice guideline | 2012 | 4 |
| 19 | 2004 | 3 | |
| 20 | Use of the epidermal growth factor receptor inhibitors gefitinib and erlotinib in the treatment of non-small cell lung cancer: a clinical practice guideline | 2006 | 3 |
About W.K. Evans
W.K. Evans is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Economics and Econometrics, Public Health, Environmental and Occupational Health and Surgery, having authored 31 papers that have together received 547 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Economic and Financial Impacts of Cancer (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Research Studies (4 papers), Clinical practice guidelines implementation (4 papers), Cancer, Lipids, and Metabolism (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (198 citations), Pulmonary and Respiratory Medicine (129 citations), Economics and Econometrics (118 citations), Public Health, Environmental and Occupational Health (73 citations) and Cancer Research (34 citations). W.K. Evans has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Joseph L. Pater, Pamela J. Goodwin, R. Feld, Ian D. Graham, George P. Browman, F. Shepherd, D. Ian Hodson, E. Ann Mohide, Kathleen I. Pritchard and Jean‐Marie Berthelot. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Journal of Thoracic Oncology, Lung Cancer and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.